FINANCIAL Econometrics

By Dr. David Edward Marcinko; MBA MEd

SPONSOR: http://www.MarcinkoAssociates.com

***

***

Financial econometrics is best understood as the application of statistical and mathematical tools to analyze financial data, uncover economic relationships, and improve decision‑making in markets. It sits at the intersection of finance, economics, and statistics, using quantitative methods to make sense of noisy, volatile, and often unpredictable financial environments. At its core, financial econometrics provides a disciplined way to test theories, build models, and forecast outcomes in markets where uncertainty is the norm.

Financial data is fundamentally different from many other types of economic data. Asset prices move quickly, often within milliseconds, and are influenced by a vast array of information. This makes volatility modeling one of the central tasks of financial econometrics. Volatility—the degree of variation in asset prices—is not constant. It clusters, meaning periods of high volatility tend to be followed by more high volatility. Models such as ARCH and GARCH were developed to capture this behavior, allowing analysts to estimate how risk evolves over time. These models are widely used by financial institutions to manage portfolios, set risk limits, and comply with regulatory requirements.

***

***

Another major area of financial econometrics is asset pricing. Asset pricing models attempt to explain why different assets earn different returns. The Capital Asset Pricing Model (CAPM) was an early attempt to link expected returns to market risk, but empirical evidence revealed its limitations. This led to multifactor models, which incorporate additional sources of risk such as size, value, and momentum. Financial econometrics plays a crucial role in testing these models, evaluating whether the factors truly explain returns or whether they arise from statistical noise. By rigorously analyzing historical data, econometricians help determine which models hold up in real markets.

Financial econometrics is also essential for forecasting. Forecasts are used for everything from predicting stock returns to estimating interest rate movements. Time series models, such as ARIMA and VAR, allow analysts to capture patterns in data and project them forward. While no model can perfectly predict the future, well constructed forecasts help investors and policymakers make more informed decisions. For example, central banks rely on econometric models to anticipate inflation trends and adjust monetary policy accordingly.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Refer and Subscribe

***

UNITED HEALTHCARE’S: Move to Remove Prior Authorization for 30% of Services

By Dr. David Edward Marcinko; MBA MEd

SPONSOR: http://www.MarcinkoAssociates.com

***

***

UnitedHealthcare’s decision to eliminate prior authorization requirements for nearly 30% of its medical services marks a significant shift in how one of the nation’s largest insurers manages care. Prior authorization has long been a point of tension among patients, clinicians, and insurers. By reducing its use, UnitedHealthcare signals a recognition that the system must evolve toward greater efficiency, trust, and patient‑centered care

Prior authorization is a process in which insurers require clinicians to obtain approval before delivering certain treatments, medications, or procedures. The stated purpose is to ensure that care is medically necessary and cost‑effective. However, the process often introduces delays, administrative burdens, and frustration for both patients and providers. Many clinicians argue that prior authorization can interfere with timely care, while patients frequently experience it as an obstacle during moments when they are already vulnerable. UnitedHealthcare’s decision to scale back this requirement acknowledges these concerns and attempts to strike a new balance between oversight and access.

The removal of prior authorization for a substantial portion of services suggests a shift toward a more trust‑based model. Instead of requiring approval for routine or low‑risk procedures, UnitedHealthcare appears to be placing greater confidence in clinicians’ judgment. This aligns with the broader movement toward reducing administrative friction in healthcare. The prior authorization process has been criticized for consuming time that could otherwise be spent on patient care. By eliminating it for many services, UnitedHealthcare may help reduce paperwork, phone calls, and appeals that have historically strained provider relationships.

One of the most meaningful impacts of this change may be improved patient experience. When a patient needs a diagnostic test, therapy, or procedure, waiting for insurer approval can create anxiety and uncertainty. Removing prior authorization for common services can shorten the time between diagnosis and treatment, allowing patients to move forward more quickly. This shift may also reduce the number of canceled or rescheduled appointments caused by pending approvals. In a system where delays can worsen health outcomes, even small reductions in administrative barriers can have significant effects.

For clinicians, the change may offer relief from a long‑standing administrative burden. Many medical practices dedicate staff solely to navigating prior authorization requirements. By reducing the volume of services requiring approval, UnitedHealthcare may free up resources within clinics and hospitals. This could allow providers to focus more on direct patient care and less on navigating insurer processes. The provider‑insurer relationship may also improve as friction decreases and communication becomes more streamlined.

However, the decision also raises questions about how UnitedHealthcare will maintain oversight and manage costs. Prior authorization has historically been used to prevent unnecessary or duplicative care. Without it, the insurer must rely on alternative strategies such as retrospective reviews, data analytics, or value‑based care models. These approaches may offer more nuanced oversight, but they also require robust infrastructure and clear communication with providers. The shift toward value‑based care may become even more central as insurers seek to align incentives without relying heavily on pre‑approval processes.

Another consideration is how this change may influence other insurers. UnitedHealthcare is a major player in the healthcare market, and its decisions often set trends. If this reduction in prior authorization proves successful—improving patient satisfaction, reducing administrative costs, and maintaining quality—other insurers may follow suit. This could lead to a broader transformation in how care is authorized and delivered across the country. The competitive dynamics of health insurance may accelerate this shift as companies seek to differentiate themselves through improved patient and provider experience.

Still, the success of this policy change will depend on careful implementation. Providers must clearly understand which services no longer require authorization, and communication must be consistent across networks. Patients must be reassured that reduced oversight will not compromise quality or safety. And UnitedHealthcare must monitor outcomes closely to ensure that the change achieves its intended goals. The balance between access and oversight remains delicate, and ongoing evaluation will be essential.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Refer and Subscribe

***